Adalimumab Exemptia

Product Description

Exemptia 40mg Injection contains the active ingredient Adalimumab. It is an antirheumatic agent that belongs to the class of medications called TNF (tumor necrosis factor) inhibitors. It is used alone or with other medications to relieve the symptoms of certain autoimmune disorders. It is used to treat rheumatoid arthritis (a condition in which the body attacks its joints, causing pain, swelling, and loss of function), polyarticular juvenile idiopathic arthritis (a condition that affects children in which the body attacks its own joints, causing pain, swelling, loss of function, and delays in growth and development).

It is also indicated to treat enthesitis-related arthritis, ankylosing spondylitis (a condition in which the body attacks the joints of the spine and other areas, causing pain and joint damage), axial spondyloarthritis without radiographic evidence of ankylosing spondylitis, psoriatic arthritis (a condition that causes joint pain and swelling and scales on the skin), plaque psoriasis,  hidradenitis suppurativa (a skin disease that causes pimple-like bumps in the armpits, groin, and anal area), Crohns disease, ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum), and non-infectious uveitis (swelling and inflammation of different areas of the eye). 

Do not use Exemptia 40mg Injection if you are allergic to adalimumab or any of the other ingredients present in this medicine. Do not take this medicine if you have active tuberculosis or other severe infections. Do not consume this medicine if you have moderate or severe heart failure. Inform your physician if you have any active infection before starting the treatment. Tell your doctor if you have lung problems, heart diseases, liver or kidney disorders before initiating the treatment. If you are pregnant, think you may be pregnant, or are planning to have a baby, ask your doctor for advice about taking this medicine.

Targeted Relief for Autoimmune Disorders

Exemptia is specially formulated for the management of chronic autoimmune diseases. By reducing inflammation and modifying immune activity, it helps alleviate symptoms associated with conditions like rheumatoid arthritis, Crohn's disease, and plaque psoriasis, thereby improving patients' quality of life and daily functioning.


Convenient Subcutaneous Administration

This injectable solution is provided in a ready-to-use, pre-filled syringe for subcutaneous injection. Healthcare professionals or trained caregivers can administer the dose, making it easier for patients to follow their prescribed treatment regimen with accuracy and minimal discomfort.


Strict Quality and Safety Standards

Manufactured in India by Cadila Healthcare Ltd., Exemptia is a sterile, single-use biologic that meets stringent safety and quality benchmarks. Its packaging and storage requirements protect product efficacy, ensuring patients receive potent, reliable therapy with every dose.